Developing a Nutritional Supplement to Increase Collagen Synthesis in People

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-30
SponsorUniversity of California, Davis

About this trial

The purpose of this study is to test whether a natural product supplement can potentiate the increase in collagen synthesis following the ingestion of collagen protein. The investigators have developed a model of natural (GRAS certified) products that stimulate collagen synthesis, in vitro. The investigators will determine whether the natural product supplement can potentiate the collagen synthetic response to the ingestion of collagen protein. Basal and fed serum will be isolated and these samples will be used to treat human engineered ligaments.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Young healthy adults (18-30 y)

Disqualifiers

Pregnancy

Smoking

Receiving any medication that may interfere with the study outcomes

Trial design

Design model

Crossover

Treatments tested in this trial

  • Natural Product Supplement

    Dietary supplement

    Participants will have blood drawn before and one hour after consuming the natural product supplement. For 7-days the participants will perform load-bearing exercise and consume the supplement. On the final day, blood will be collected 4 hours after the final exercise bout.

  • Placebo control

    Dietary supplement

    Participants will have blood drawn before and one hour after consuming the placebo supplement. For 7-days the participants will perform load-bearing exercise and consume the supplement. On the final day, blood will be collected 4 hours after the final exercise bout.

Treatment groups

20 Participants
are divided into 2 treatment groups
Group A: Natural Product SupplementExperimental treatment 1 intervention
Group B: PlaceboPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Collagen protein synthesis

Collagen protein synthesis will be indirectly measured by measuring pro-collagen type I N-terminal propeptide (PINP) in the serum before and 4 hours after the last exercise bout (at day 7 of the protocol).

Time frame
7 days

Secondary outcomes

1

Strength of ligament constructs

Serum from participants will be used to treat engineered ligaments in order to measure the effect of the supplementation on the strength of the ligaments. The strength will be measured using the Instron bio puls 68SC-1 tension and compression machine.

Time frame
60 minutes post-exercise
2

Collagen content of ligament constructs

Ligament constructs will be treated for 7 days with experimental feed medium containing serum obtained at baseline or post-prandial for determination of collagen content using a hydroxyproline assay.

Time frame
60 minutes post-exercise

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.